Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Is Wall Street Bullish or Bearish on Merck Stock?

Valued at $199.1 billion by market cap, Merck & Co., Inc. (MRK) is a leading American biopharmaceutical company based in Rahway, New Jersey. With a strong global presence, Merck develops prescription medicines, vaccines, biologic therapies, and animal health products, chiefly across oncology, immunology, infectious disease, and cardio-metabolic areas.

Shares of Merck have slid 30.3% over the past year, significantly lagging behind the S&P 500 Index’s ($SPX) 14.5% rise. This downward trend has persisted into 2025, with MRK down 20.3% year-to-date, in sharp contrast to the S&P 500’s 6.1% gain.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.